Intellipharmaceutics International Inc (NASDAQ:IPCI)

0.6982
Delayed Data
As of Feb 16
 -0.0718 / -9.32%
Today’s Change
0.66
Today|||52-Week Range
2.92
-12.72%
Year-to-Date
No recent news for Intellipharmaceutics International Inc.

Today’s Trading

Previous close0.77
Today’s open0.76
Day’s range0.66 - 0.76
Volume966,123
Average volume (3 months)344,791
Market cap$24.2M
Data as of 3:59pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+23.68%
Earnings growth (this year)--
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+144.97%
P/E ratioNM
Price/Sales4.77
Price/Book62.73

Competitors

 Today’s
change
Today’s
% change
SLNOSoleno Therapeutics ...-0.11-6.36%
CTXRCitius Pharmaceutica...+0.30+8.62%
VKTXViking Therapeutics ...-0.05-0.80%
ARCTArcturus Therapeutic...+0.25+4.53%
Data as of 4:00pm ET, 02/16/2018

Financials

Last reporting dateFebruary 8, 2018
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$5.5M
Annual profit (last year)-$8.9M
Net profit margin-160.91%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO &
Co-Chief Scientific Officer
Isa Odidi
President, Chief Operating Officer &
Director
Amina Odidi
Corporate headquarters
Toronto, Ontario

Forecasts